510(k) Report

510(k) · Cleared

Recalled · Class II · 2015

Salterlabs 8660 Series Nebulizer

K962879510(k) TraditionalCleared Oct 22, 199690-day reviewClass II21 CFR 868.5630Recalls 1

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Salter Labs · CAF Nebulizer (Direct Patient Interface)

Cleared on Oct 22, 1996 as substantially equivalent to K870027 (Salter Labs, 1987) after a 90-day review. Its family tree reaches back 1 generation to 1987. 4 later devices descend from it. It has been recalled once.

Decided
Oct 22, 1996
Review
90 days
Class
Class II
Product code
CAF
Recalls
1
Predicates
1

Its longest line of descent runs back 1 generation to K870027 (1987). 4 later devices descend from it, 3 citing it directly.

Descendants, by year cleared 2013: 1 descendant cleared2007: 1 descendant cleared2008: 1 descendant cleared2023: 1 descendant clearedK870027 · Hand Held Pheumatic Powered (Disposable) Nebulizer · Salter Labs · 1987 · recalled1990200020102020
Descendants, by generation 1 generation forward: 3 descendants2 generations forward: 1 descendant K870027 · Hand Held Pheumatic Powered (Disposable) Nebulizer · Salter Labs · 1987 · recalled0
  1. Root · 1 generation backK870027 Hand Held Pheumatic Powered (Disposable) NebulizerSalter Labs · 1987 · Recalled
  2. This deviceK962879 Salterlabs 8660 Series NebulizerSalter Labs · 1996
  3. Descendant · cites it directly · 1 of its ownK123527 AirlifeCare Fusion · 2013
  4. Descendant · 2 generations on · 0 of its ownK230602 Hudson RCI® TurboMist™ Nebulizer SystemMedline Industries, LP · 2023
  5. Descendant · cites it directly · 0 of its ownK080969 Healthline Redi-Neb Medication Nebulizer, Model RN-510Medi Nuclear Corp., Inc. · 2008
  6. Descendant · cites it directly · 0 of its ownK062484 Flaem Nuova RF6 Basic and RF6 Plus NebulizersFlaem Nuova S.P.A. · 2007

Most influential descendants

Showing 4 of 4 · See all
  • K123527AirlifeCare Fusion · 2013 · cites it directly1descendant
  • K230602Hudson RCI® TurboMist™ Nebulizer SystemMedline Industries, LP · 2023 · 2 generations on0descendants
  • K080969Healthline Redi-Neb Medication Nebulizer, Model RN-510Medi Nuclear Corp., Inc. · 2008 · cites it directly0descendants
  • K062484Flaem Nuova RF6 Basic and RF6 Plus NebulizersFlaem Nuova S.P.A. · 2007 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−1K870027Hand Held Pheumatic Powered (Disposable) NebulizerSalter Labs19871
0 (this device)K962879Salterlabs 8660 Series NebulizerSalter Labs1996—
+1K123527AirlifeCare Fusion2013—
+2K230602Hudson RCI® TurboMist™ Nebulizer SystemMedline Industries, LP2023—
+1K080969Healthline Redi-Neb Medication Nebulizer, Model RN-510Medi Nuclear Corp., Inc.2008—
+1K062484Flaem Nuova RF6 Basic and RF6 Plus NebulizersFlaem Nuova S.P.A.2007—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
200710
200810
201310
202310
FIG. 1 — Lineage of K962879, 1987–2023Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in CAF? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new CAF device

  1. #1 K260270 FindAir ONE for pMDI (FAO-MDI-V12-GRE-001)score 13.2 · 7 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K870027Hand Held Pheumatic Powered (Disposable) Nebulizer
Summary page 1
…eries 15.5 Identification of Predicate Device: Salter Labs Hand Held Pneumatic Powered (disposable) Nebulizer Model 8900, which was cleared for marketing by 510(k) No, K870027. 15.6 Description of the Device: Each of the Salter Labs 8660 Series Nebulizers consists of a Nebulizer Top which is screwed on…
Salter Labs19871

Also cleared against K870027: 5 other devices →

What descends from it? (4)

3 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K123527AirlifeCare Fusion20131
K080969Healthline Redi-Neb Medication Nebulizer, Model RN-510Medi Nuclear Corp., Inc.20080
K062484Flaem Nuova RF6 Basic and RF6 Plus NebulizersFlaem Nuova S.P.A.20070

Has anything in its family been recalled? (0 Class I)

Recalls of this device

DateClassRecallRoot causeReason
Aug 4, 2015Class IIZ-2781-2015Component change controlThe Inspiratory valve cap on the nebulizer reservoir tower may be loose and may detach before or during treatment.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Its one ancestor has a recall.
  • Of its descendants, K123527 (Care Fusion, 2013) has gone furthest, with 1 descendant of its own.
  • 5 other devices also cite its predicate K870027.

How does its category compare?

All CAF devices

CAF Nebulizer (Direct Patient Interface): FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · CAF

7in 2025

2007: 182008: 122009: 82010: 102011: 102012: 92013: 92014: 92015: 82016: 52017: 82018: 92019: 32020: 62021: 82022: 42023: 82024: 42025: 72026 (partial year): 2
2007high 18 (2007) · low 3 (2019)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · CAF

211in 2025

2007: 98 days median2008: 123 days median2009: 163 days median2010: 114 days median2011: 157 days median2012: 126 days median2013: 238 days median2014: 151 days median2015: 186 days median2016: 186 days median2017: 253 days median2018: 161 days median2019: 266 days median2020: 219 days median2021: 324 days median2022: 176 days median2023: 279 days median2024: 251 days median2025: 211 days median
2007high 324 (2021) · low 98 (2007)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · CAF

1in 2018

2007: 12011: 12014: 52015: 32016: 12017: 14, 13 Class I2018: 1
2007high 14 (2017) · low 0 (2008)2026

Class I (13 since 2007) Class II/III not classified

Adverse event reports per year · CAF

191in 2025

2007: 262008: 112009: 152010: 372011: 2372012: 1382013: 2172014: 1232015: 1662016: 2012017: 2562018: 1622019: 1852020: 1172021: 1612022: 552023: 1072024: 1022025: 191
2007high 256 (2017) · low 11 (2008)2025

MAUDE reports naming product code CAF, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20071898126
200812123011
20098163015
201010114037
2011101571237
201291260138
201392380217
201491515123
201581863166
201651861201
2017825314 (13)256
201891611162
201932660185
202062190117
202183240161
20224176055
202382790107
202442510102
202572110191
20262—0—

What is it indicated for?

The Model 8660 Series Nebulizers have the same intended use as their predicate device, The Salter Model 8900 Nebulizer, which was cleared for marketing by 510(k) No. K870027. The nebulizer is a reusable single patient use device (whereas the 8900 is a disposable single patient use device) which is used where liquids are to be delivered to a patient in an aerosol form. The device is not life-supporting or life-sustaining, nor is it implanted. It does not…

Read the full statement (122 words)

The Model 8660 Series Nebulizers have the same intended use as their predicate device, The Salter Model 8900 Nebulizer, which was cleared for marketing by 510(k) No. K870027. The nebulizer is a reusable single patient use device (whereas the 8900 is a disposable single patient use device) which is used where liquids are to be delivered to a patient in an aerosol form. The device is not life-supporting or life-sustaining, nor is it implanted. It does not use software, nor is it sterile, although it must be cleaned or disinfected per the label instructions before reuse. The device is for single patient use. It is intended to be used with accessories, such tubing which is an industry standard device used with nebulizers.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K962879: Salterlabs 8660 Series Nebulizer.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K962879

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026